Prohost Letter #403 Part 2
Continued From Wednesday
Instead of continuing yesterday article about Agenus, we decided to post it all so that the reader can find it in one place. Important changes and additions have been made especially under the headline “Near-Term Priorities, Possibilities and Catalysts”, which are important to read.
Learning More About
Since its inception, Agenus (AGEN), previously known as Antigenics, trading with the same symbol was focused on immune system boosters, including vaccines and adjuvants. The firm is one of a few firms that . . .